SCHEMBL9111285

SCHEMBL9111285

[CH2]C=CCCc1ccc2occc2c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 4/20 0.44
CYP2A6 P11509 2/20 0.41
CHRM2 P08172 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
DYRK1A Q13627 3/20 0.36
CDK9 P50750 1/20 0.35
EPM2A O95278 1/20 0.35
PTPRC P08575 1/20 0.35
PTPN6 P29350 1/20 0.35
CDC14A Q9UNH5 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
CTNNB1 P35222 3/20 0.35
WNT3A P56704 3/20 0.35
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
SLC6A4 P31645 1/20 0.33
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956802 0.80 CYP2A6 (0.51) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL9113881 0.78 CHRM2 (0.52) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL2095978 0.78 HTR1B (0.50) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL4451104 0.74 HTR1B (0.50) HTR1BCYP2A6DYRK1ACDK9EPM2A
SCHEMBL3792011 0.74 HTR1B (0.55) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL4521327 0.74 HTR1B (0.50) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL4526570 0.74 HTR1B (0.50) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL14051551 0.74 HTR1B (0.50) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL2763193 0.74 HTR1B (0.50) HTR1BCYP2A6CHRM2CHRM1CHRM3
SCHEMBL13714002 0.73 HTR1B (0.53) HTR1BCYP2A6DYRK1ACDK9EPM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed